Craneware Reports 52% Profit Surge and Rejects Unsolicited Takeover Bid in FY25 Results

FY25: profit surge, higher margins and momentum across Craneware

Craneware’s FY25 numbers show a business leaning into its strengths in US hospital finance software. Revenue rose 9% to $205.7m, margins edged up, and statutory profit before tax jumped 52% to $24.0m. Behind the headline figures: stronger expansion with existing customers, improving contract quality and a growing contribution from the Trisus platform and 340B “Shelter” programme.

The Board also disclosed – and rejected – an unsolicited approach at £26.50 per share during the year, signalling clear confidence in the strategy and medium-term growth potential.

Key FY25 numbers investors should know

Metric	FY25	FY24	Change
Revenue	$205.7m	$189.3m	+9%
Annual Recurring Revenue (ARR)	$184.0m	$172.0m	+7%
Net Revenue Retention (NRR)	107%	98%	+9ppt
Adjusted EBITDA	$65.3m	$58.3m	+12%
Adjusted EBITDA margin	32%	31%	+1ppt
Statutory profit before tax	$24.0m	$15.7m	+52%
Adjusted basic EPS	116.1 cents	94.8 cents	+22.5%
Basic EPS	56.2 cents	33.5 cents	+68%
Operating cash conversion	94%	90%	+4ppt
Total cash	$55.9m	$34.6m	+61%
Total bank debt	$27.7m	$35.4m	-$7.7m
Gross margin	87%	86%	+1ppt
Total dividend	32.0p	29.0p	+10%

What drove the beat: expansion sales, sticky customers and platform progress

Two commercial indicators stand out. First, customer retention stayed above 90%, which is excellent by software standards. Secondly, expansion sales to existing customers made up 98% of new sales (FY24: 83%). That tells you hospitals are buying more modules and rolling Trisus out across wider networks.

ARR rose 7% to $184.0m and Net Revenue Retention improved to 107%. Quick refresher: ARR is the annualised value of subscription and other recurring revenues at period-end. NRR measures how revenue from the same customer set changes over a year after churn and upsells – over 100% means the base is expanding. Craneware’s 107% shows upsell comfortably outweighed any attrition.

The Trisus platform is doing heavier lifting. Non-recurring platform revenues increased to $20.0m (FY24: $13.8m), with the 340B “Shelter” programme a key contributor. Importantly, customers are now transitioning Shelter to a recurring model, adding to ARR as planned.

Microsoft alliance and AI credentials are real commercial levers

The strategic partnership with Microsoft advanced: 13 Trisus solutions are now on Azure Marketplace, first customer contracts have been signed through the Marketplace, and joint go-to-market activities have begun. Trisus Chargemaster – Craneware’s flagship revenue integrity tool – received Microsoft “AI for Healthcare” certification and retained “Best in KLAS”.

During the year, Craneware launched Trisus Assist, an AI-powered assistant initially embedded in Chargemaster, now being rolled out across product sets including 340B. The combination of proprietary data from 200+ million patient encounters and Microsoft’s tooling is a differentiator, in my view, particularly as US providers look for fast, measurable ROI rather than moonshots.

Cash flow, balance sheet and the new $100m RCF

Cash generation remains a hallmark. Operating cash conversion was 94% of Adjusted EBITDA. Cash rose to $55.9m while total bank debt reduced to $27.7m. On the company’s alternative metrics, that puts Craneware in a net cash position of $28.2m at year-end.

After the period, Craneware secured a new unsecured $100m revolving credit facility on improved terms, with an additional $100m accordion and options to extend. That replaces the previous term loan and RCF and lowers interest costs – helpful for both optionality and earnings quality.

Dividend increased and underpinned by multi‑year contracts

The Board proposed a final dividend of 18.5p per share (FY24: 16.0p), taking the total to 32.0p (FY24: 29.0p), up 10%. The subscription model is doing what it should: contracted recurring revenue hit $176.2m (FY24: $168.3m), and the backlog of unsatisfied performance obligations stood at $326.2m, with $128.6m expected to be recognised within one year.

Board rejected £26.50 per share approach

During H2, the company received an unsolicited outline proposal to acquire Craneware at £26.50 per share. The Board did not enter formal negotiations and unanimously rejected the approach in June, restating confidence in the company’s prospects. Shareholder feedback post-announcement was described as supportive.

Takeaway: management believes there is more value to create independently, backed by an accelerating growth profile, stronger margins and the Microsoft alliance.

Why this matters for retail investors

• Quality of growth improved: NRR rose to 107%, expansion sales dominated, and gross margins reached 87%.
• Cash discipline intact: 94% cash conversion, rising cash and lower debt support ongoing R&D and a higher dividend.
• Strategic positioning: AI-enabled Trisus applications, a data advantage and Azure Marketplace distribution can shorten sales cycles and deepen wallet share.

The balanced view: positives and watch‑outs

• Positives: clear operating leverage (Adjusted EBITDA up 12% on 9% revenue growth), strong retention, and the transition of platform activity into recurring revenue. Finance costs fell, lifting statutory PBT by 52%.
• Watch‑outs: overall revenue growth is still single-digit. A portion of platform revenue remains non-recurring at this stage. The 340B environment is subject to regulatory change, which the company monitors.
• One-offs: the effective tax rate benefited from a $1.5m reversal related to prior tax matters; without it, management indicates the FY25 effective tax rate would have been 24% (reported: 18%).

Outlook and what to track in FY26

Management says trading in the first months of the new year has started well, and the combined ARR/NRR gains provide confidence in “continued growth acceleration” in FY26. The balance sheet and new credit facility give room to invest and consider acquisitions that add data, customers, expertise or US‑relevant applications.

KPIs to watch next

• ARR growth vs revenue growth – management expects closer alignment as more platform revenues become recurring.
• NRR consistency around or above 100% – a sign expansion continues to offset churn.
• Azure Marketplace traction – additional contracts and shorter sales cycles would confirm channel momentum.
• Contribution from Trisus Assist and broader AI features – evidence of efficiency gains and upsell.
• Cash conversion and margins – holding the 30%+ Adjusted EBITDA margin while investing around 25% of revenue in R&D.

Josh’s take

This is a high-quality update from Craneware. The model is doing the heavy lifting – sticky customers, expanding deployments and improving economics. The Microsoft alliance and AI credentials are more than marketing gloss; they are beginning to move the commercial needle. The valuation question sits outside this RNS, but the Board’s rejection of a £26.50 approach tells you where they think the runway leads.

Net-net: momentum up, balance sheet stronger, dividend higher. If ARR growth does indeed accelerate as platform revenues convert to subscriptions, FY26 could mark the inflection the Board is aiming for.